BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19843888)

  • 1. Putting risk prediction in perspective: relative utility curves.
    Baker SG
    J Natl Cancer Inst; 2009 Nov; 101(22):1538-42. PubMed ID: 19843888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating Prognostic Markers Using Relative Utility Curves and Test Tradeoffs.
    Baker SG; Kramer BS
    J Clin Oncol; 2015 Aug; 33(23):2578-80. PubMed ID: 26124476
    [No Abstract]   [Full Text] [Related]  

  • 3. ROC curves for clinical prediction models part 1. ROC plots showed no added value above the AUC when evaluating the performance of clinical prediction models.
    Verbakel JY; Steyerberg EW; Uno H; De Cock B; Wynants L; Collins GS; Van Calster B
    J Clin Epidemiol; 2020 Oct; 126():207-216. PubMed ID: 32712176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating Risk Prediction with Data Collection Costs: Novel Estimation of Test Tradeoff Curves.
    Baker SG
    Med Decis Making; 2024 Jan; 44(1):53-63. PubMed ID: 37990924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating a new marker for risk prediction: decision analysis to the rescue.
    Baker SG; Kramer BS
    Discov Med; 2012 Sep; 14(76):181-8. PubMed ID: 23021372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical inference for decision curve analysis, with applications to cataract diagnosis.
    Sande SZ; Li J; D'Agostino R; Yin Wong T; Cheng CY
    Stat Med; 2020 Sep; 39(22):2980-3002. PubMed ID: 32667093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple Decision-Analytic Functions of the AUC for Ruling Out a Risk Prediction Model and an Added Predictor.
    Baker SG
    Med Decis Making; 2018 Feb; 38(2):225-234. PubMed ID: 29025299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-class ROC analysis--a decision theoretic approach under the ideal observer framework.
    He X; Metz CE; Tsui BM; Links JM; Frey EC
    IEEE Trans Med Imaging; 2006 May; 25(5):571-81. PubMed ID: 16689261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing Decision-Analysis Performances of Risk Prediction Models Using ADAPT Curves.
    Lee WC; Wu YC
    Medicine (Baltimore); 2016 Jan; 95(2):e2477. PubMed ID: 26765451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calibration of risk prediction models: impact on decision-analytic performance.
    Van Calster B; Vickers AJ
    Med Decis Making; 2015 Feb; 35(2):162-9. PubMed ID: 25155798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.
    Vickers AJ; Cronin AM; Elkin EB; Gonen M
    BMC Med Inform Decis Mak; 2008 Nov; 8():53. PubMed ID: 19036144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Prediction Models for Lung Cancer: A Systematic Review.
    Gray EP; Teare MD; Stevens J; Archer R
    Clin Lung Cancer; 2016 Mar; 17(2):95-106. PubMed ID: 26712102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graphics and statistics for cardiology: clinical prediction rules.
    Woodward M; Tunstall-Pedoe H; Peters SA
    Heart; 2017 Apr; 103(7):538-545. PubMed ID: 28179372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating a new marker for risk prediction using the test tradeoff: an update.
    Baker SG; Van Calster B; Steyerberg EW
    Int J Biostat; 2012 Mar; 8(1):. PubMed ID: 22499728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using relative utility curves to evaluate risk prediction.
    Baker SG; Cook NR; Vickers A; Kramer BS
    J R Stat Soc Ser A Stat Soc; 2009 Oct; 172(4):729-748. PubMed ID: 20069131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature.
    Kluth LA; Black PC; Bochner BH; Catto J; Lerner SP; Stenzl A; Sylvester R; Vickers AJ; Xylinas E; Shariat SF
    Eur Urol; 2015 Aug; 68(2):238-53. PubMed ID: 25709027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility as a rationale for choosing observer performance assessment paradigms for detection tasks in medical imaging.
    Wunderlich A; Abbey CK
    Med Phys; 2013 Nov; 40(11):111903. PubMed ID: 24320436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures.
    Van Calster B; Vickers AJ; Pencina MJ; Baker SG; Timmerman D; Steyerberg EW
    Med Decis Making; 2013 May; 33(4):490-501. PubMed ID: 23313931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.